Clinical Transparency Proponents Question Safety and Efficacy of Russia’s COVID-19 Vaccine

Russia surprised the world Tuesday when the government of that country announced its regulatory agency approved the world’s first COVID-19 vaccine – a vaccine that has yet to go through Phase III testing.

While Russian President Vladimir Putin expressed confidence in the preventative medication against the novel coronavirus, scientists from across the globe expressed concern over the lack of available data that could provide a key to how well the drug could work stemming the rise of COVID-19.